NCT00405951View on ClinicalTrials.gov

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

September 30, 2009

Conditions
Lung Cancer
Interventions
DRUG

Obatoclax mesylate 250 ml

DRUG

Docetaxel

Trial Locations (7)

20007

Georgetown University, Washington D.C.

21201

University of Maryland, Baltimore

21225

MedStar Research Institute, Baltimore

33612

H. Lee Moffitt Cancer Center, Tampa

76012

Arlington Cancer Center, Arlington

85259

Mayo Clinic College of Medicine, Scottsdale

90210

Tower Oncology, Beverly Hills

Sponsors

Lead Sponsor

Gemin X
All Listed Sponsors
lead

Gemin X

INDUSTRY

NCT00405951 - Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter